Reference number : 236-2018-2019-Q1-00278, amendment number : , agreement type : G, recipient legal name : Malard, Camille, recipient country : CA, recipient province : QC, recipient city : Montreal, recipient postal code : H3A 2T5, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 17500.0, agreement start date : 2018-05-01, agreement end date : 2019-04-30, description english : Efficacy, toxicity, and delivery methods of therapeutic ribonucleic acids (RNAs) for use in human immunodeficeincy virus (HIV) stem cell therapy, description french : Efficacy, toxicity, and delivery methods of therapeutic ribonucleic acids (RNAs) for use in human immunodeficeincy virus (HIV) stem cell therapy, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada